You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Aminopiperidines as novel anti influenza agents
SBC: Chicago Biosolutions, Inc. Topic: NIAIDInfluenza A viruses belong to the orthomyxoviridae family with a negative sense segmented RNA genome which can cause seasonal or pandemic flu with high morbidity and significant mortality Vaccination is the most prevalent prophylactic means for controlling influenza infections However an effective vaccine usually takes at least months to develop for the circulating strains Furthermore vac ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Monochromatic 222 nm UV light: Development of a safe, cost-effective technology for the efficient reduction of bacterial and viral infection and transmission
SBC: EDEN PARK ILLUMINATION, INC. Topic: NIAIDDESCRIPTION provided by applicant Drug resistant bacteria such as MRSA and airborne transmitted microbes such as influenza and TB together present major health issues both in the developed and the developing world with major health care and economic consequences Recent research from Columbia University Medical Center demonstrated that single wavelength far UVC photons can kill bacteria a ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A chimeric protein for the selective expansion of regulatory T cells
SBC: SAHANE BIOTECH INC Topic: NIAIDDESCRIPTION provided by applicant Type diabetes T D is a chronic disease caused by the autoimmune destruction of the insulin producing beta cells in the pancreas Current treatment options for T D are severely limited All patients diagnosed with T DM are placed on life long insulin therapy and the current standard of care for adult patients with T DM is intensive diabetes therapy to avoid ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Developing a method to increase HIV testing among YMSM
SBC: RESILIENT GAMES STUDIO, LLC Topic: NICHDDESCRIPTION provided by applicant Adolescents are particularly vulnerable to HIV and account for one quarter of all new infections each year Most new infections among adolescents occur among young men who have sex with men YMSM Transmission of HIV can be virtually eliminated by treatment but testing rates are low and a significant proportion of YMSM are unaware of their HIV status P ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
NMDA RECEPTOR MODULATORS AS NOOTROPIC THERAPIES IN AGING BRAIN
SBC: Aptinyx Inc Topic: NIADESCRIPTION provided by applicant Age related memory loss is a growing public health issue which will be magnified in the coming decades by increasing life expectancies and the aging baby boomer population Age is the most important risk factor for developing dementia of the population between and has some form of dementia between and and of those or older The the ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
An Ultra filtrate perfusion bio artificial pancreas for high-density islet replacement without immunosuppression
SBC: Norfolk Medical Products, INC. Topic: NIDDKDESCRIPTION provided by applicant The Cell SafeTM is a fundamentally new approach in replacement of dysfunctional insulin producing cells in patients with diabetes by transplantation of new islets in a three dimensional scaffold embedded in a highly compatible bioengineered perfusion system that continuously supplies tissue fluid blood ultrafiltrate so that the cells ae protected from immun ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Screening for pancreatic cancer via nanocytology of duodenal cells
SBC: NANOCYTOMICS LLC Topic: NCIDESCRIPTIONprovided by applicantThe goal of this SBIR project is to develop a minimally intrusivehighly sensitive risk stratification tool to determine the need for invasive pancreatic cancerPCscreeningPC is theth leading cause of cancer deaths in the USWhile early stage disease is generally curablethe vast majority of patients are diagnosed in advancedunresectable stages due in large part to the ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A Holographic Waveguide Display Based Low Vision Eyewear
SBC: BIOLIGHT ENGINEERING LLC Topic: NDESCRIPTION provided by applicant Low vision rehabilitation is the only proven way to restore functional vision and maintain a high quality of life in patients with permanent vision impairment Low vision aids are devices that manipulate visual information for example magnify images to compensate for impaired vision The patientandapos s willingness to accept a low vision aid ability to ada ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Simultaneous Multifunction Control of Powered Upper-Limb Prostheses
SBC: Coapt LLC Topic: NICHDDESCRIPTION provided by applicant Pattern recognition PR myoelectric control systems can dramatically improve an amputee patientandapos s control of a powered prosthesis but they still require that the user perform sequential movements to achieve a task Coapt LLC is an early stage company that has initiated a controlled commercial release of PR myoelectric control for the benefit of upper ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Engineered aldolase for the fermentative production of L-fucose and other rare sugars.
SBC: ZUCHEM INC. Topic: 300DESCRIPTION provided by applicant The goal of this proposal is to develop a fermentative strategy for the large scale production of L fucose and other rare sugars L fucose deoxy L galactose is an important hexose deoxysugar found in a variety of organisms attached to an array of macromolecules These L fucose containing glycans exhibit a wide range of medicinal properties including support ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health